Clinical Trial Update: Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and pharmacokinetics of N1539 in children aged 2 to under 17 years after surgery; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• N1539

Snippet

Sponsor: Baudax Bio | Conditions: Post Operative Pain | Phase 4 | Status: TERMINATED | Results posted: 2023-09-13